Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.

TrumpRx is supposed to launch in early 2026. Here's what we know about how buying medicine through the site to get discounts ...

Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

Some of the top-grossing drugs include Merck's Keytruda, an immunotherapy for multiple cancers with almost $30 billion in ...

Drugmakers are planning to raise the prices of at least 350 drugs in 2026, despite their pledges to offer reduced prices ...

With Johnson & Johnson’s participation, 15 of 17 companies contacted by the administration over the summer have now signed on ...

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Deep ...

While the Trump administration remains unpredictable, some pharma experts are optimistic that the regulatory landscape will ...

The plant will focus on serving health care companies by developing and commercializing medical devices, drug delivery ...

Oregon is joining cities, unions, and states across the country that have filed lawsuits alleging pharmacy benefit mangers ...